Knight Therapeutics's total assets for Q4 2025 were C$1.05B, a decrease of -0.22% from the previous quarter. KHTRF total liabilities were C$279.03M for the fiscal quarter, a -0.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.